Expeditors (EXPD) Form 144 Discloses Insider Sale of 2,500 Shares
Rhea-AI Filing Summary
Form 144 notice for Expeditors International of Washington, Inc. (EXPD) reporting a proposed sale of 2,500 common shares through Charles Schwab & Co., Inc. with an approximate sale date of 09/05/2025 and an aggregate market value of $303,800.00. The issuer has 135,718,520 shares outstanding. The shares were acquired on 05/23/2019 as stock grants (amount acquired shown as 14,545) and the consideration is listed as equity compensation. The filer reports no securities sold in the past three months and signs the standard representation that they are not aware of any undisclosed material adverse information about the issuer.
Positive
- Transparent compliance with Rule 144 disclosure requirements showing broker, dates, quantities, and value
- No sales reported in the past three months, simplifying aggregation rules under Rule 144
Negative
- Insider sale disclosed (2,500 shares), which could be interpreted negatively by some investors despite being small relative to shares outstanding
Insights
TL;DR: Routine Rule 144 notice disclosing an insider sale of 2,500 shares; procedural compliance apparent.
The filing is a standard Form 144 disclosure showing a proposed Rule 144 sale executed through Charles Schwab with specific share counts and aggregate value disclosed. The acquisition history identifies the position as originating from stock grants on 05/23/2019 and paid as equity compensation, consistent with typical insider compensation conversions. No prior sales in the past three months are reported, which simplifies the aggregation requirements under Rule 144. From a compliance standpoint, the form contains the required elements: broker, approximate sale date, share totals, and the insider representation about material nonpublic information.
TL;DR: Disclosure is routine and provides transparency into an insider liquidity event without indicating material governance change.
The notice documents a planned sale by a person who received shares via stock grants in 2019. The filing does not identify the seller by name in the provided content nor indicate any extraordinary circumstances such as accelerated vesting, related-party transactions, or material corporate events. As presented, this is a routine liquidity action by an equity holder and does not, by itself, signal governance concerns. Investors may note the sale size relative to outstanding shares (2,500 vs 135.7M) is immaterial to overall capitalization.